CELERA™
Placental-Derived Allograft

CELERA™ human amnion chorion membrane allografts are minimally manipulated and dehydrated. They are intended for use as a wound cover or skin substitute for cutaneous wounds.
CELERA™ provides a Human Biocompatible Extracellular Matrix (ECM)
CELERA allografts retain the structural and functional characteristics of native placental membranes, and they provide a human biocompatible extracellular matrix (ECM).
Product Advantages
CELERA allografts are intended for use by qualified healthcare professionals for application in a physician office, outpatient, or inpatient setting.

Compatibility
Compatible with compression therapy, Negative Pressure Wound Therapy (NPWT) and Hyperbaric Oxygen Therapy (HBOT)

Shelf Stable*
5-year shelf life

Safety
Terminally sterilized for additional level of safety
